April 1, 2015 — Medtronic plc announced the initiation of the SPYRAL HTN Global Clinical Trial Program, a phased ...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
February 12, 2015 — Ablative Solutions Inc. announced the addition of Michael Weber, M.D., FACP, FACC, FAHA, to its ...
February 10, 2015 — Younger adults with elevated systolic blood pressure have a higher risk for cardiovascular disease ...
February 5, 2015 — Ostar Healthcare Technology announced the North American launch of their Cellular P201 telehealth blo ...
February 4, 2015 — Ostar Healthcare Technology, a Washington State Based TeleHealth Solutions company, announced the ...
The America College of Cardiology has released its list of key late-breaking clinical trials at the ACC 2015 meeting in ...
January 19, 2015 — The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx ...
December 23, 2014 — The most accessed research studies in the Journal of the American College of Cardiology (JACC) in ...
November 17, 2014 — VIVA Physicians, a not-for-profit organization in the field of vascular medicine and intervention ...
October 8, 2014 — St. Jude Medical Inc. announced 12-month outcome data from the EnligHTN III study, which demonstrated ...
September 2, 2014 — Boston Scientific has released the primary endpoint results from its NEural Cardiac TherApy foR ...
September 2, 2014 — Renal denervation reduces recurrent atrial fibrillation (AF) when performed with pulmonary vein ...
August 28, 2014 — Renal artery stenting to open blockages in the kidney arteries may benefit patients who have ...
August 26, 2014 — The mantra for treatment for high blood pressure has been "the lower, the better," but that goal can ...
Peter G. Maxim, Ph.D., assistant professor of radiation oncology at Stanford University, discusses stereotactic ...